LB PharmaceuticalsCommon Stock Net Income

As of the most recent data (June 2026), LBRX shows a net income of $-86M. That is below the Healthcare sector average of $16B. Scroll down for historical charts and peer comparison views.

The Healthcare sector average net income is about $16B. LB PharmaceuticalsCommon Stock is at $-86M, which is lower that average. That is roughly 100.5% below the sector mean. Use the comparison chart on this page to see how LBRX stacks up against individual peers as well.

Tracking LBRX's net income over time shows whether LB PharmaceuticalsCommon Stock is scaling, shrinking, or reshaping that part of the business. The current reading is $-86M Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this net income page, Stockcircle has LB PharmaceuticalsCommon Stock's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect net income (currently $-86M) with ownership activity and broader fundamentals.

The Healthcare average net income is about $16B, while LBRX is at $-86M. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.